Advertisement
Advertisement

PHAT

PHAT logo

Phathom Pharmaceuticals, Inc. Common Stock

12.56
USD
Sponsored
+0.03
+0.24%
May 13, 15:59 UTC -4
Closed
exchange

Pre-Market

12.60

+0.04
+0.32%

Phathom Pharmaceuticals, Inc. Common Stock Profile

About

Phathom Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel treatments for gastrointestinal diseases. The company's product pipeline consists of vonoprazan, which are in clinical stage. Phathom Pharmaceuticals Inc. is based in Buffalo Grove, United States.

Info & Links

CEO

Steven Basta

Headquarters

100 CAMPUS DRIVE, SUITE 102
FLORHAM PARK, NJ 07932, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.phathompharma.com

Auditor

Ernst & Young LLP

Share holders

56

Employees

371

Phathom Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1B

Enterprise Value

1.08B

Enterprise Value/EBITDA(ttm)

-6.93

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

5.73

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

87.10%

Operating Margin(ttm)

-102.32%

Profit Margin(ttm)

-154.97%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

130.71%

Return on Assets(ttm)

-68.66%

Income Statement

Revenue(ttm)

175.11M

Revenue Per Share(ttm)

2.22

Gross Profit(ttm)

152.51M

EBITDA(ttm)3

-156.34M

Net Income Available to Common(ttm)

-221.25M

Diluted EPS(ttm)

-3.06

Share Statistics

Beta (5Y Monthly)

0.61

52-Week Change

279.46%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

78.80M

Dividend Yield

0.00%

Float4

61.16M

% Held by Insiders

23.00%

% Held by Institutions

99.01%

Balance Sheet

Total Cash(mrq)

129.97M

Total Cash Per Share(mrq)

1.65

Total Debt(mrq)

209.09M

Total Debt/Equity(mrq)

-47.72%

Current Ratio(mrq)

1.73%

Quick Ratio(mrq)

1.69%

Book Value Per Share(mrq)

-6.14

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.29

Free Cash Flow(ytd)

-167.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement